Literature DB >> 7691031

Down-regulation and release of CD14 on human monocytes by IL-4 depends on the presence of serum or GM-CSF.

J Ruppert1, C Schütt, D Ostermeier, J H Peters.   

Abstract

IL-4 induces down-regulation of CD14 expression on human monocytes only when the cells are cultured with serum. In serum-free cultures we failed to down-regulate CD14 by IL-4. Instead of serum, GM-CSF was required as a co-factor to restore the regulatory effect of IL-4 on CD14-expression. After 4 days of culture human monocytes were quantitatively CD14-negative as determined by flow-cytometry. On day 6, high amounts of CD14 molecules were detected in the SUP of these cultures, whereas intracellular immunofluorescence staining revealed no detectable CD14 in cytokine-treated monocytes. Thus, CD14 is lost by down-regulation (as shown by others) as well as by delivery into the medium. We previously hypothesized that dendritic cells may originate from monocytes. Our present finding support that one of the key markers, distinguishing monocytes/macrophages from dendritic cells, can be lost upon physiological stimuli.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7691031     DOI: 10.1007/978-1-4615-2930-9_47

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  9 in total

1.  Thyroid associated ophthalmopathy: evidence for CD4(+) gammadelta T cells; de novo differentiation of RFD7(+) macrophages, but not of RFD1(+) dendritic cells; and loss of gammadelta and alphabeta T cell receptor expression.

Authors:  A K Eckstein; B Quadbeck; S Tews; K Mann; C Krüger; C H Mohr; K-P Steuhl; J Esser; R K Gieseler
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

2.  Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes.

Authors:  M I de Moraes-Pinto; G S Vince; B F Flanagan; C A Hart; P M Johnson
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

3.  Selective depletion of cultured macrophages by magnetite nanoparticles modified with gelatin.

Authors:  Yoshihiro Komohara; Ryuta Kawauchi; Erika Makiyama; Kazuki Mikami; Hasita Horlad; Yukio Fujiwara; Tetsuya Kida; Motohiro Takeya; Takuro Niidome
Journal:  Exp Ther Med       Date:  2017-06-21       Impact factor: 2.447

4.  A novel dendritic cell-based immunization approach for the induction of durable Th1-polarized anti-HER-2/neu responses in women with early breast cancer.

Authors:  Gary K Koski; Ursula Koldovsky; Shuwen Xu; Rosemarie Mick; Anupama Sharma; Elizabeth Fitzpatrick; Susan Weinstein; Harvey Nisenbaum; Bruce L Levine; Kevin Fox; Paul Zhang; Brian J Czerniecki
Journal:  J Immunother       Date:  2012-01       Impact factor: 4.456

5.  Daily exposure to dust alters innate immunity.

Authors:  Karin Sahlander; Kjell Larsson; Lena Palmberg
Journal:  PLoS One       Date:  2012-02-15       Impact factor: 3.240

6.  B cell, CD8 + T cell and gamma delta T cell infiltration alters alveolar immune cell homeostasis in HIV-infected Malawian adults.

Authors:  Andrew Mwale; Annemarie Hummel; Leonard Mvaya; Raphael Kamng'ona; Elizabeth Chimbayo; Joseph Phiri; Rose Malamba; Anstead Kankwatira; Henry C Mwandumba; Kondwani C Jambo
Journal:  Wellcome Open Res       Date:  2018-04-06

7.  A Human Cell Line Model for Interferon-α Driven Dendritic Cell Differentiation.

Authors:  Jurjen M Ruben; Lindy L Visser; Kimberley M Heinhuis; Tom O'Toole; Hetty J Bontkes; Theresia M Westers; Gert J Ossenkoppele; Tanja D de Gruijl; Arjan A van de Loosdrecht
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 8.  On the origin of myeloid-derived suppressor cells.

Authors:  Camilla Rydberg Millrud; Caroline Bergenfelz; Karin Leandersson
Journal:  Oncotarget       Date:  2017-01-10

9.  Generating Bovine Monocyte-Derived Dendritic Cells for Experimental and Clinical Applications Using Commercially Available Serum-Free Medium.

Authors:  Jack Guinan; Brina S Lopez
Journal:  Front Immunol       Date:  2020-10-16       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.